The serotonin 1A (5-HT1A) receptor as a pharmacological target in depression
Clinical depression is a common, debilitating and heterogenous disorder. Existing treatments for depression are inadequate for a significant minority of patients and new approaches are urgently needed. A wealth of evidence implicates the serotonin 1A (5-HT1A) receptor in the pathophysiology of depre...
Κύριοι συγγραφείς: | Smith, ALW, Harmer, CJ, Cowen, PJ, Murphy, SE |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Springer Nature
2023
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial
ανά: de Cates, AN, κ.ά.
Έκδοση: (2024) -
Translating the promise of 5HT4 receptor agonists for the treatment of depression
ανά: Murphy, SE, κ.ά.
Έκδοση: (2020) -
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
ανά: Colwell, MJ, κ.ά.
Έκδοση: (2022) -
Pharmacological characterization of a 5-HT1-type serotonin receptor in the red flour beetle, Tribolium castaneum.
ανά: Rut Vleugels, κ.ά.
Έκδοση: (2013-01-01) -
Déjà-vu? Neural and behavioural effects of the 5-HT4 receptor agonist, prucalopride, in a hippocampal-dependent memory task
ανά: de Cates, AN, κ.ά.
Έκδοση: (2021)